French MPs OK bill raising industry levy and imposing price cuts
This article was originally published in Scrip
The lower house of the French parliament has passed the 2012 social security financing bill (PLFSS), which among other things will increase the sales-based contribution on the pharmaceutical industry, boost the use of generics and impose drug price cuts, as part of a drive to keep healthcare spending within set limits.
You may also be interested in...
Coronavirus Notebook: EU Publishes CureVac Vaccine Contract, AZ and Pfizer Under Attack Over Supply Cuts
The European Ombudsman has opened an inquiry regarding the disclosure of vaccine contracts with other companies, and the European Commission is planning a “sharing mechanism” for vaccines bought by EU member states.
Australia will begin its coronavirus vaccination program with Comirnaty. The Oxford University/AstraZeneca vaccine is expected to be the next to receive approval.
Hungary is going its own way when it comes to coronavirus vaccines, but its decision to allow the emergency use of the Oxford University/AstraZeneca vaccine may be only a symbolic expression of the government’s growing impatience with the EU.